By CW Staff2018-08-21T10:45:00
In an attempt to distance itself from the opioid epedemic, Purdue Pharma recently made some leadership changes to its board of directors and executive committee, as it battles hundreds of lawsuits across the United States concerning opioid-related deceptive sales and marketing practices that are the focus of U.S. enforcement authorities.
2020-02-05T16:37:00Z By Jaclyn Jaeger
Practice Fusion will pay a total of $145 million to resolve criminal and civil investigations for its leading role in an opioid kickback scheme. Particularly notable are the new compliance obligations imposed upon it, which are as weighty and significant as the fine itself.
2019-08-02T17:32:00Z By Jaclyn Jaeger
In a period of three months, two chief compliance officers have been charged for their individual roles in the opioid epidemic—a clear indication the Department of Justice continues to expand the scope of prosecutions to those who fail in their compliance responsibilities.
2025-09-05T21:03:00Z By Aly McDevitt
Nestlé dismissed its CEO over an undisclosed relationship with a subordinate, a clear breach of the company’s code of business conduct. The dismissal underscores that no one is exempt from compliance obligations, even top leadership.
Site powered by Webvision Cloud